GU Ventures
GU Ventures, established in 1995 and based in Gothenburg, Sweden, is an accelerator firm dedicated to supporting projects and companies emerging from the University of Gothenburg. Wholly owned by the Swedish state and managed by the university since 1998, GU Ventures collaborates closely with the University of Gothenburg's Research and Innovation Office as well as various local innovation partners. The firm focuses on the commercialization of research and expertise, emphasizing business ideas that demonstrate commercial viability and address customer needs. By nurturing companies primarily in the life sciences and technology sectors, GU Ventures aims to foster successful businesses that can achieve profitability and contribute positively to regional growth. The overarching goal is to generate beneficial knowledge and capital returns to the University of Gothenburg while promoting the application of research to enhance societal well-being through new products and services.
Pretzel Therapeutics is a biotechnology company focused on developing therapies for mitochondrial dysfunction. Founded by leading experts in mitochondrial biology, the company aims to create innovative treatments that address the underlying causes of mitochondrial issues. By leveraging a comprehensive understanding of mitochondrial mechanisms, Pretzel Therapeutics seeks to reverse dysfunction at its roots, potentially providing effective solutions for patients suffering from a range of conditions, including those related to aging. The company's name reflects its scientific focus on the mitochondrion, which is characterized by its unique and highly folded inner membrane, distinguishing it from other organelles in the body.
Profundus AB, based in Gothenburg, Sweden, specializes in the research and development of advanced imaging technology for retinal diagnostics. The company is developing a proof-of-concept prototype for a novel fundus camera that utilizes adaptive optics, a technology originally designed for terrestrial telescopes. This innovative approach significantly enhances imaging resolution, offering 7-10 times greater clarity than conventional devices while covering a larger area of the retina. The primary goal of Profundus AB is to create a clinical tool that aids in the diagnosis of retinal diseases by visualizing subclinical changes that may otherwise go unnoticed.
OnDosis AB develops and manufactures handheld dosing device. The company's product connects and enables patients to digital health services, including, treatment. The company was founded in 2017 and is headquartered in Gothenburg, Sweden.
Mimbly is a manufacturer of sustainable laundry systems designed to enhance water conservation in washing machines. The company's innovative add-on system connects to the washing machine's water intake valve, where it monitors, analyzes, and purifies water during each wash cycle for reuse. This technology enables professional laundry facilities to adopt more sustainable practices by significantly reducing water consumption, minimizing microplastic pollution, and lowering CO2 emissions. Mimbly's solutions aim to address environmental challenges associated with traditional laundry processes, promoting a more sustainable approach to laundry management.
Cereno Scientific AB (publ) develops preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation worldwide. Its product candidate includes CS1, a phase II dual-acting antithrombotic drug, which is for the treatment of venous thrombosis, and prevention of stroke for atrial fibrillation. It also developing histone deacetylase inhibitor that is in the preclinical stage. The company was founded in 2012 and is based in Mölndal, Sweden.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.